Publications by authors named "M Baudard"

Claim this Profile
I
Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses.
Marie Baudard, Amélie Yavchitz, Philippe Ravaud, Elodie Perrodeau, Isabelle Boutron

BMJ· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugeniu Banu, Marion Baudard

Cancer Immunol Immunother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
Reinhard Dummer, Stefan Eichmüller, Sylke Gellrich, Chalid Assaf, Brigitte Dreno, Marion Baudard

Mol Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study.
Guillaume Cartron, Lu Zhao-Yang, Marion Baudard, Tarik Kanouni, Valérie Rouillé

J Clin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
Michel Jourdan, Jérôme Moreaux, John De Vos, Dirk Hose, Karène Mahtouk, Marion Baudard

Br J Haematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis